Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab
Public ClinicalTrials.gov record NCT02304484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to characterize the safety and tolerability of long-term administration of evolocumab in adults with known coronary artery disease and hypercholesterolemia.
Study identification
- NCT ID
- NCT02304484
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 770 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 24, 2014 (Actual)
- Primary completion
- Mar 9, 2018 (Actual)
- Completion
- Mar 9, 2018 (Actual)
- Last update posted
- Mar 19, 2019
2014 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Long Beach | California | 90822 | — |
| Research Site | San Diego | California | 92161 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Munster | Indiana | 46321 | — |
| Research Site | Lexington | Kentucky | 40536 | — |
| Research Site | Covington | Louisiana | 70433 | — |
| Research Site | Bethesda | Maryland | 20814 | — |
| Research Site | Columbia | Maryland | 21044 | — |
| Research Site | Bay City | Michigan | 48708 | — |
| Research Site | Midland | Michigan | 48670 | — |
| Research Site | Duluth | Minnesota | 55805 | — |
| Research Site | Saint Cloud | Minnesota | 56303 | — |
| Research Site | Columbia | Missouri | 65212 | — |
| Research Site | Ridgewood | New Jersey | 07450 | — |
| Research Site | Fargo | North Dakota | 58122 | — |
| Research Site | Canton | Ohio | 44710 | — |
| Research Site | Toledo | Ohio | 43614 | — |
| Research Site | Oak Ridge | Tennessee | 37830 | — |
| Research Site | Amarillo | Texas | 79106 | — |
| Research Site | Dallas | Texas | 75216 | — |
| Research Site | Wichita Falls | Texas | 76301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02304484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02304484 live on ClinicalTrials.gov.